APA
ANIK icon

American Portfolios Advisors’s Anika Therapeutics ANIK Stock Holding History

American Portfolios Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-600
Closed -$29.8K – 2381
2018
Q1 		$29.8K Sell
600
-1,550
-72% -$87.6K ﹤0.01% 1225
2017
Q4 		$116K Buy
+2,150
New +$119K 0.02% 680

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

American Portfolios Advisors's ANIK Position: Q2 2018 in Review

American Portfolios Advisors sold out of Anika Therapeutics (ANIK) in Q2 2018, closing a stake of 600 shares — an estimated $29.8K sold.

American Portfolios Advisors first reported a position in ANIK in Q4 2017 and held it in 2 quarters. The position peaked at $116K in Q4 2017. 170 funds tracked by Wall St. Rank hold ANIK as of Q2 2018.

  • American Portfolios Advisors reported no remaining Anika Therapeutics position as of Q2 2018 after selling out during the quarter.
  • American Portfolios Advisors sold 600 Anika Therapeutics shares in Q2 2018, an estimated $29.8K.
  • American Portfolios Advisors first reported a position in Anika Therapeutics in Q4 2017 and held it in 2 quarters.
  • American Portfolios Advisors's Anika Therapeutics position peaked at $116K in Q4 2017.
  • 170 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2018.

Based on American Portfolios Advisors's 13F filing for Q2 2018, filed 24 Mar 2023.